AbbVie (ABBV) Financials

$256.65

$-3.57 (-1.37%)

As on 04-Sep-2026 13:42EDT

Market cap

$459,822 Mln

Revenue (TTM)

$64,386 Mln

P/E Ratio

74.1

P/B Ratio

50.5

Div. Yield

2.6 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	64,386.00	61,160.00	56,334.00	54,318.00	58,054.00	56,197.00
Cost of Revenue	18,365.00	18,204.00	16,904.00	20,415.00	17,414.00	17,446.00
Gross Profit	46,021.00	42,956.00	39,430.00	33,903.00	40,640.00	38,751.00
Operating Expenses	27,142.00	22,865.00	30,293.00	21,146.00	22,523.00	20,827.00
Operating Profit (EBIT)	18,879.00	20,091.00	9,137.00	12,757.00	18,117.00	17,924.00
Other Income	--	--	--	--	-2,596.00	-2,551.00
Profit before Tax	8,699.00	6,597.00	3,716.00	6,250.00	13,477.00	12,989.00
Provision for Tax	2,383.00	2,364.00	-570.00	1,377.00	1,632.00	1,440.00
Profit after Tax (Net Income)	6,314.00	4,226.00	4,278.00	4,863.00	11,836.00	11,542.00
Minority Interest	-6.00	-7.00	-8.00	-10.00	-9.00	-7.00
Consolidated Profit	--	--	--	--	11,836.00	11,542.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	-5,935.00	-3,228.00	3,364.00	10,397.00	17,287.00	15,436.00
Minority Interest	-6.00	--	--	37.00	33.00	28.00
Non-Current Liabilities	99,361.00	93,899.00	93,048.00	86,473.00	91,980.00	95,899.00
Current Liabilities	41,642.00	43,289.00	38,749.00	37,841.00	29,538.00	35,194.00
Total Liabilities	176,757.00	133,960.00	135,161.00	134,711.00	138,805.00	146,529.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	101,446.00	104,898.00	109,579.00	101,709.00	110,342.00	118,601.00
Current Assets	33,669.00	29,062.00	25,582.00	33,002.00	28,463.00	27,928.00
Total Assets	176,776.00	133,960.00	135,161.00	134,711.00	138,805.00	146,529.00
Total Debt*	70,822.00	69,068.00	67,841.00	60,120.00	64,191.00	77,575.00
Net Current Assets	-7,973.00	-14,227.00	-13,167.00	-4,839.00	-1,075.00	-7,266.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	19,030.00	18,806.00	22,839.00	24,943.00	22,777.00
Cash Flow from Investing Activities	--	-6,643.00	-20,820.00	-2,009.00	-623.00	-2,344.00
Cash from Financing Activities	--	-12,724.00	-5,211.00	-17,222.00	-24,803.00	-19,039.00
Net Cash Inflow / Outflow	--	--	--	--	-483.00	1,297.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	3.56	2.38	2.41	2.74	6.66	6.49
Cash EPS ($)	3.51	6.97	7.14	7.65	11.42	11.28
Adjusted Book Value ($)	-3.36	--	1.90	5.87	9.72	8.68
Dividend per Share ($)	2.61	--	--	--	--	--
Cash Flow per Share ($)	--	10.73	10.61	12.89	14.03	12.81
Free Cash Flow per Share ($)	--	10.04	10.06	12.45	13.64	12.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	6.17	6.04	6.40	13.57	11.95
ROE (%)	--	6,214.71	62.18	35.13	72.34	80.90
ROA (%)	3.57	3.14	3.17	3.56	8.30	7.77
EBIT Margin (%)	20.68	15.52	11.58	15.60	27.06	27.42
Net Margin (%)	9.81	6.91	7.59	8.95	21.34	21.52
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	10.39	0.09	0.04	-0.06	0.03	0.23
EBIT Growth (%)	125.97	45.46	-23.01	-46.05	1.91	163.36
Net Profit Growth (%)	67.99	-1.22	-12.03	-58.91	2.55	150.04
EPS Growth (%)	67.77	-0.01	-0.12	-0.59	0.03	1.50
Book Value Growth (%)	-4,203.16	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	74.13	95.92	73.65	56.47	24.28	20.86
Price / Book Value	50.46	-125.57	93.66	26.41	16.62	15.60
Dividend Yield (%)	2.61	--	--	--	--	--
EV/EBITDA	26.88	26.61	25.31	18.75	14.16	12.89
Close Price ($)	251.64	228.49	177.70	154.97	161.61	135.40
High Price ($)	255.96	244.81	207.32	168.11	175.91	136.83
Low Price ($)	184.39	164.39	153.58	130.96	128.26	101.81
Market Cap ($ Cr)	459,821.58	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	-10.53	-21.40	20.17	5.78	3.71	5.03
Short term debt to equity ratio	-1.41	-2.71	2.02	0.69	0.25	0.82
Current Ratio	0.81	0.67	0.66	0.87	0.96	0.79
Quick Ratio	0.69	0.56	0.55	0.76	0.84	0.70
Interest Coverage	3.98	3.28	2.32	3.81	7.04	6.36

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	21.47	20.58	19.38	20.54	19.39	17.75
Asset Turnover	0.36	0.45	0.42	0.40	0.41	0.38
Receivable days	--	70.20	71.56	75.34	66.79	61.09
Inventory Days	--	91.61	89.45	68.68	70.34	67.39
Payable days	--	65.58	71.66	59.24	60.99	53.99
Cash Conversion Cycle	--	96.23	89.35	84.79	76.13	74.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)